Loren Mell

Title(s)Professor, Radiation Medicine and Applied Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford University, Stanford, CaliforniaB.S.06/1996Mathematics
    Stanford University, Stanford, CaliforniaB.A.06/1996Economics
    University of Chicago, Chicago, IllinoisM.D.06/2003Medicine
    University of Chicago, Chicago, IllinoisResidency06/2008Radiation Oncology

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Multi-atlas and whole body radiomics approaches for image-guided treatment of gynecologic cancers
    NIH R01CA255780Mar 1, 2020 - Feb 29, 2024
    Role: Principal Investigator
    Effectiveness of IG-IMRT for Locally Advanced Cervix Cancer on NRG Trial CVM-1421
    NIH R01CA197059Jul 2, 2015 - Jun 30, 2020
    Role: Principal Investigator
    Image-guided bone marrow-sparing IMRT for cervical cancer
    NIH R21CA162718Sep 12, 2011 - Aug 31, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Nomogram to predict risk of early mortality following definitive or adjuvant radiation and systemic therapy for head and neck cancer. Clin Transl Radiat Oncol. 2024 Mar; 45:100725. Raab G, Yu Y, Sherman E, Wong R, Mell LK, Lee NY, Zakeri K. PMID: 38304239; PMCID: PMC10832379.
      View in: PubMed   Mentions:
    2. Computational and AI-driven 3D structural analysis of human papillomavirus (HPV) oncoproteins E5, E6, and E7 reveal significant divergence of HPV E5 between low-risk and high-risk genotypes. Virology. 2024 Feb; 590:109946. Jones RN, Miyauchi S, Roy S, Boutros N, Mayadev JS, Mell LK, Califano JA, Venuti A, Sharabi AB. PMID: 38147693.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Adjuvant Radiation in Resectable Node-Positive Merkel Cell Carcinoma in the Immunotherapy Era: Implications for Future and Ongoing Trials. Cancers (Basel). 2023 Nov 23; 15(23). Riviere P, Dornisch AM, Sanghvi P, Mell LK. PMID: 38067253; PMCID: PMC10705163.
      View in: PubMed   Mentions:
    4. Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus Head and Neck Carcinoma: A Phase 2 Randomized Clinical Trial. JAMA Oncol. 2023 Nov 01; 9(11):1565-1573. Wong SJ, Torres-Saavedra PA, Saba NF, Shenouda G, Bumpous JM, Wallace RE, Chung CH, El-Naggar AK, Gwede CK, Burtness B, Tennant PA, Dunlap NE, Redman R, Stokes WA, Rudra S, Mell LK, Sacco AG, Spencer SA, Nabell L, Yao M, Cury FL, Mitchell DL, Jones CU, Firat S, Contessa JN, Galloway T, Currey A, Harris J, Curran WJ, Le QT. PMID: 37768670; PMCID: PMC10540060.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    5. SMAD4 loss predicts worse overall and distant metastasis-free survival in patients with resected pancreatic adenocarcinoma. Cancer. 2024 Feb 01; 130(3):476-484. Anstadt EJ, Carmona R, Berlin E, Yegya-Raman N, Venigalla S, Reddy V, Williams GR, Leibensperger MR, Wojcieszynski A, Baumann BC, Lee MK, Plastaras JP, Furth EE, Mell LK, Metz JM, Ben-Josef E. PMID: 37823514.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. JAMA Oncol. 2023 06 01; 9(6):800-807. Ryu S, Deshmukh S, Timmerman RD, Movsas B, Gerszten P, Yin FF, Dicker A, Abraham CD, Zhong J, Shiao SL, Tuli R, Desai A, Mell LK, Iyengar P, Hitchcock YJ, Allen AM, Burton S, Brown D, Sharp HJ, Dunlap NE, Siddiqui MS, Chen TH, Pugh SL, Kachnic LA. PMID: 37079324; PMCID: PMC10119775.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    7. Transoral Surgery in HPV-Positive Oropharyngeal Carcinoma: Oncologic Outcomes in the Veterans Affairs System. Laryngoscope. 2024 Jan; 134(1):207-214. Faraji F, Kumar A, Voora R, Soliman SI, Cherry D, Courtney PT, Finegersh A, Guo T, Cohen E, Califano JA, Mell L, Rose B, Orosco RK. PMID: 37255050; PMCID: PMC10687307.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Optimized Atlas-Based Auto-Segmentation of Bony Structures from Whole-Body Computed Tomography. Pract Radiat Oncol. 2023 Sep-Oct; 13(5):e442-e450. Gao L, Yusufaly TI, Williamson CW, Mell LK. PMID: 37030539.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Good Radiosensitizer Hunting. J Clin Oncol. 2023 05 01; 41(13):2313-2318. Mell LK, Wong SJ. PMID: 36724418.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Problems With Interpreting Treatment Effects in Observational Competing Risks Data. JAMA Otolaryngol Head Neck Surg. 2023 02 01; 149(2):183. Mell LK. PMID: 36480179.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial. Eur Urol. 2024 Apr; 85(4):373-381. Mell LK, Pugh SL, Jones CU, Nelson TJ, Zakeri K, Rose BS, Zeitzer KL, Gore EM, Bahary JP, Souhami L, Michalski JM, Hartford AC, Mishra MV, Roach M, Parliament MB, Choi KN, Pisansky TM, Husain SM, Malone SC, Horwitz EM, Feng F. PMID: 36710205; PMCID: PMC10372191.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline Q and A. JCO Oncol Pract. 2023 04; 19(4):194-196. Yilmaz E, Ismaila N, Dabney R, Saba NF, Mell LK. PMID: 36701647.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Treatment Considerations for Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin. Curr Treat Options Oncol. 2023 03; 24(3):147-161. Kim SS, Liu HC, Mell LK. PMID: 36696081; PMCID: PMC9992074.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Outcomes from a 3-fraction high-dose-rate brachytherapy regimen for patients with cervical cancer. Brachytherapy. 2023 May-Jun; 22(3):317-324. Williamson CW, Kotha NV, Zou J, Brown D, Scanderbeg D, Rash D, Einck J, Yashar C, Mell LK, Mayadev J. PMID: 36631374.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline. J Clin Oncol. 2023 02 10; 41(5):1132-1146. Yilmaz E, Ismaila N, Bauman JE, Dabney R, Gan G, Jordan R, Kaufman M, Kirtane K, McBride SM, Old MO, Rooper L, Saba NF, Sheth S, Subramaniam RM, Wise-Draper TM, Wong D, Mell LK. PMID: 36521102.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    16. Quantitative prediction of aspiration risk in head and neck cancer patients treated with radiation therapy. Oral Oncol. 2022 Nov 19; 136:106247. Liu HC, Williamson CW, Zou J, Todd JR, Nelson TJ, Hill LM, Linnemeyer KE, Henderson G, Madgula P, Faung B, Sacco AG, Vitzthum LK, Weissbrod PA, Blumenfeld LS, Mell LK. PMID: 36410204.
      View in: PubMed   Mentions: 4     Fields:    
    17. Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504. Int J Radiat Oncol Biol Phys. 2023 03 15; 115(4):847-860. Gillison ML, Ferris RL, Harris J, Colevas AD, Mell LK, Kong C, Jordan RC, Moore KL, Truong MT, Kirsch C, Chakravarti A, Blakaj DM, Clump DA, Ohr JP, Deeken JF, Gensheimer MF, Saba NF, Dorth JA, Rosenthal DI, Leidner RS, Kimple RJ, Machtay M, Curran WJ, Torres-Saavedra P, Le QT. PMID: 36228746.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. Incomplete cisplatin regimens in chemoradiation and its effect on outcomes for locally advanced cervical cancer. Int J Gynecol Cancer. 2022 Oct 06. Kotha NV, Williamson CW, Marra KV, McHale M, Mell LK, Mayadev JS. PMID: 36202426.
      View in: PubMed   Mentions:    Fields:    
    19. Adjuvant Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Carcinoma with Adverse Pathological Features. Cancers (Basel). 2022 Sep 17; 14(18). Soliman SI, Faraji F, Pang J, Mell LK, Califano JA, Orosco RK. PMID: 36139676; PMCID: PMC9496867.
      View in: PubMed   Mentions: 1  
    20. 18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002. J Nucl Med. 2023 03; 64(3):362-367. Subramaniam RM, DeMora L, Yao M, Yom SS, Gillison M, Caudell JJ, Waldron J, Xia P, Chung CH, Truong MT, Echevarria M, Chan JW, Geiger JL, Mell L, Seaward S, Thorstad WL, Beitler JJ, Sultanem K, Blakaj D, Le QT. PMID: 36215572; PMCID: PMC10071810.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    21. Imaging Biomarkers and Liquid Biopsy in Assessment of Cervical Cancer. J Comput Assist Tomogr. 2022 Sep-Oct 01; 46(5):707-715. Ghani MA, Liau J, Eskander R, Mell L, Yusufaly T, Obrzut S. PMID: 35995483; PMCID: PMC9474655.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Management of Older Adults with Locally Advanced Head and Neck Cancer. Cancers (Basel). 2022 Jun 05; 14(11). Dickstein DR, Lehrer EJ, Hsieh K, Hotca A, Jones BM, Powers A, Sharma S, Liu J, Gupta V, Mell L, Husain Z, Kirke D, Misiukiewicz K, Posner M, Genden E, Bakst RL. PMID: 35681789; PMCID: PMC9179912.
      View in: PubMed   Mentions: 3  
    23. Disparities in time to start of definitive radiation treatment for patients with locally advanced cervical cancer. Int J Gynecol Cancer. 2022 05 03; 32(5):613-618. Kotha NV, Williamson CW, Mell LK, Murphy JD, Martinez E, Binder PS, Mayadev JS. PMID: 35428688.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Bias Reduction through Analysis of Competing Events (BRACE) Correction to Address Cancer Treatment Selection Bias in Observational Data. Clin Cancer Res. 2022 05 02; 28(9):1832-1840. Williamson CW, Nelson TJ, Thompson CA, Vitzthum LK, Zakeri K, Riviere PJ, Bryant AK, Sharabi AB, Zou J, Mell LK. PMID: 35140122.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. J Natl Compr Canc Netw. 2022 03; 20(3):224-234. Caudell JJ, Gillison ML, Maghami E, Spencer S, Pfister DG, Adkins D, Birkeland AC, Brizel DM, Busse PM, Cmelak AJ, Colevas AD, Eisele DW, Galloway T, Geiger JL, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Mell LK, Mittal BB, Pinto HA, Rocco JW, Rodriguez CP, Savvides PS, Schwartz D, Shah JP, Sher D, St John M, Weber RS, Weinstein G, Worden F, Yang Bruce J, Yom SS, Zhen W, Burns JL, Darlow SD. PMID: 35276673.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    26. Validation of NRG Oncology's prognostic nomograms for oropharyngeal cancer in the Veterans Affairs database. Cancer. 2022 05 15; 128(10):1948-1957. Nelson TJ, Thompson CA, Zou J, Kumar A, Sangchan P, Williamson CW, Vitzthum LK, Sharabi AB, Murphy JD, Fakhry CA, Mell LK. PMID: 35194791.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    27. Reply: Adding Nontumor Radiomic Features to the Prognostic Model Is Bothersome but Useful. J Nucl Med. 2022 Mar; 63(3):495. Yusufaly TI, Mell LK. PMID: 35027373.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. SMARCA4-Deficient Carcinoma of Uterine Cervix Resembling SCCOHT-Case Report. Pathol Oncol Res. 2021; 27:1610003. Sirák I, Laco J, Vošmiková H, Mell LK, Herrera FG, Šenkeríková M, Vošmik M. PMID: 34970085; PMCID: PMC8712336.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Trials and tribulations of bone marrow sparing radiotherapy for cervical cancer. Re: Zhou et al. Radiother Oncol. 2021;165:103-118. Radiother Oncol. 2022 02; 167:78-80. Mell LK. PMID: 34896460.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    30. Improved Prognosis of Treatment Failure in Cervical Cancer with Nontumor PET/CT Radiomics. J Nucl Med. 2022 07; 63(7):1087-1093. Yusufaly TI, Zou J, Nelson TJ, Williamson CW, Simon A, Singhal M, Liu H, Wong H, Saenz CC, Mayadev J, McHale MT, Yashar CM, Eskander R, Sharabi A, Hoh CK, Obrzut S, Mell LK. PMID: 34711618; PMCID: PMC9258568.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    31. Patterns of Failure After Definitive Treatment of T4a Larynx Cancer. Otolaryngol Head Neck Surg. 2022 08; 167(2):274-285. Voora RS, Panuganti BA, Flagg M, Nelson T, Kotha NV, Qiao EM, Qian AS, Kumar A, Stewart TF, Rose B, Califano J, Weissbrod PA, Mell LK, Orosco RK. PMID: 34609937.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    32. Evaluation of dose differences between intracavitary applicators for cervical brachytherapy using knowledge-based models. Brachytherapy. 2021 Nov-Dec; 20(6):1323-1333. Kallis K, Mayadev J, Covele B, Brown D, Scanderbeg D, Simon A, Frisbie-Firsching H, Yashar CM, Einck JP, Mell LK, Moore KL, Meyers SM. PMID: 34607771.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities. Front Oncol. 2021; 11:738626. Saddawi-Konefka R, Simon AB, Sumner W, Sharabi A, Mell LK, Cohen EEW. PMID: 34621678; PMCID: PMC8490924.
      View in: PubMed   Mentions: 4  
    34. Quality improvement intervention to reduce time to postoperative radiation in head and neck free flap patients. Head Neck. 2021 11; 43(11):3530-3539. Voora RS, Stramiello JA, Sumner WA, Finegersh A, Mohammadzadeh A, Fouania J, Ramsey C, Blumenfeld L, Sacco AG, Mell LK, Califano JA, Orosco RK. PMID: 34492135.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    35. Keeping Kids Kool-Influence of Induction, Advantage of Adaptation, Curtailment of Complications. Int J Radiat Oncol Biol Phys. 2021 09 01; 111(1):12-13. Sumner WA, Mell LK. PMID: 34348107.
      View in: PubMed   Mentions:    Fields:    
    36. Positron Emission Tomography-Guided Bone Marrow-Sparing Radiation Therapy for Locoregionally Advanced Cervix Cancer: Final Results From the INTERTECC Phase II/III Trial. Int J Radiat Oncol Biol Phys. 2022 01 01; 112(1):169-178. Williamson CW, Sirák I, Xu R, Portelance L, Wei L, Tarnawski R, Mahantshetty U, Heide ES, Yashar CM, McHale MT, Bosch W, Lowenstein J, Saenz CC, Plaxe S, Eskander R, Einck J, Mundt AJ, Mayadev J, Mell LK. PMID: 34419564; PMCID: PMC8688221.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    37. Knowledge-based dose prediction models to inform gynecologic brachytherapy needle supplementation for locally advanced cervical cancer. Brachytherapy. 2021 Nov-Dec; 20(6):1187-1199. Kallis K, Mayadev J, Kisling K, Brown D, Scanderbeg D, Ray X, Cortes K, Simon A, Yashar CM, Einck JP, Mell LK, Moore KL, Meyers SM. PMID: 34393059.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. End of treatment cone-beam computed tomography (CBCT) is predictive of radiation response and overall survival in oropharyngeal squamous cell carcinoma. Radiat Oncol. 2021 Aug 09; 16(1):147. Sumner W, Kim SS, Vitzthum L, Moore K, Atwood T, Murphy J, Miyauchi S, Califano JA, Mell LK, Mundt AJ, Sharabi AB. PMID: 34372887; PMCID: PMC8351145.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    39. Advances in External Beam Radiation Therapy and Brachytherapy for Cervical Cancer. Clin Oncol (R Coll Radiol). 2021 09; 33(9):567-578. Williamson CW, Liu HC, Mayadev J, Mell LK. PMID: 34266728.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    40. Letter to the Editor, Re: Reitblat et al. 2021. Urol Oncol. 2021 10; 39(10):740-741. Williamson CW, Mell LK. PMID: 34261586.
      View in: PubMed   Mentions:    Fields:    
    41. Public access to protocols of contemporary cancer randomized clinical trials. Trials. 2021 Jun 27; 22(1):418. Babu C, Mell L, Lee N, Zakeri K. PMID: 34176506; PMCID: PMC8237482.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    42. NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer. Cancers (Basel). 2021 Jun 09; 13(12). Bauman JE, Harris J, Uppaluri R, Yao M, Ferris RL, Chen J, Jordan RC, Joshi NP, Jujjuvaparu S, Blakaj DM, Henson C, Sheqwara J, Mell LK, Sen N, Clump DA, Garg MK, Yilmaz E, Torres-Saavedra P, Le QT. PMID: 34207599; PMCID: PMC8230356.
      View in: PubMed   Mentions: 4  
    43. High rates of postoperative radiotherapy delay in head and neck cancer before and after Medicaid expansion. Head Neck. 2021 09; 43(9):2672-2684. Pang J, Faraji F, Risa E, Mell LK, Houlton JJ, Califano JA. PMID: 33998088.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance. JAMA Netw Open. 2021 05 03; 4(5):e219452. Nelson TJ, Javier-DesLoges J, Deka R, Courtney PT, Nalawade V, Mell L, Murphy J, Parsons JK, Rose BS. PMID: 33999164; PMCID: PMC8129822.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    45. Immunotherapy and radiation therapy sequencing: State of the data on timing, efficacy, and safety. Cancer. 2021 05 15; 127(10):1553-1567. Williamson CW, Sherer MV, Zamarin D, Sharabi AB, Dyer BA, Mell LK, Mayadev JS. PMID: 33620731; PMCID: PMC9376883.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    46. Racial, Ethnic, and Socioeconomic Discrepancies in Opioid Prescriptions Among Older Patients With Cancer. JCO Oncol Pract. 2021 06; 17(6):e703-e713. Vitzthum LK, Nalawade V, Riviere P, Sumner W, Nelson T, Mell LK, Furnish T, Rose B, Martínez ME, Murphy JD. PMID: 33534647; PMCID: PMC8258011.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    47. Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002). J Clin Oncol. 2021 03 20; 39(9):956-965. Yom SS, Torres-Saavedra P, Caudell JJ, Waldron JN, Gillison ML, Xia P, Truong MT, Kong C, Jordan R, Subramaniam RM, Yao M, Chung CH, Geiger JL, Chan JW, O'Sullivan B, Blakaj DM, Mell LK, Thorstad WL, Jones CU, Banerjee RN, Lominska C, Le QT. PMID: 33507809; PMCID: PMC8078254.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansCellsCTClinical Trials
    48. Validation of an oncology-specific opioid risk calculator in cancer survivors. Cancer. 2021 05 01; 127(9):1529-1535. Riviere P, Vitzthum LK, Nalawade V, Deka R, Furnish T, Mell LK, Rose BS, Wallace M, Murphy JD. PMID: 33378556.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. In Reply to Sari et al. Int J Radiat Oncol Biol Phys. 2020 11 15; 108(4):1116-1117. Mell LK, Xu R, Saenz CC. PMID: 33069341.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Predictive classifier for intensive treatment of head and neck cancer. Cancer. 2020 12 15; 126(24):5263-5273. Zakeri K, Rotolo F, Lacas B, Vitzthum LK, Le QT, Gregoire V, Overgaard J, Hackshaw A, Zackrisson B, Parmar MKB, Burtness BA, Ghi MG, Sanguineti G, O'Sullivan B, Fortpied C, Bourhis J, Shen H, Harris J, Michiels S, Pignon JP, Mell LK, MARCH/MACH-NC Collaborative Group and the Head and Neck Cancer Intergroup. PMID: 33017867.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    51. Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer. Semin Radiat Oncol. 2020 10; 30(4):273-280. Feng CH, Mell LK, Sharabi AB, McHale M, Mayadev JS. PMID: 32828383.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    52. Knowledge-Based Planning for Intact Cervical Cancer. Semin Radiat Oncol. 2020 Oct; 30(4):328-339. Yusufaly TI, Meyers SM, Mell LK, Moore KL. PMID: 32828388.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    53. Current Status of Clinical Trials for Cervical and Uterine Cancer Using Immunotherapy Combined With Radiation. Int J Radiat Oncol Biol Phys. 2021 02 01; 109(2):396-412. Dyer BA, Feng CH, Eskander R, Sharabi AB, Mell LK, McHale M, Mayadev JS. PMID: 32942005.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    54. NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. Int J Radiat Oncol Biol Phys. 2021 02 01; 109(2):413-424. Small W, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK. PMID: 32905846; PMCID: PMC7856050.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    55. Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing Chemoradiotherapy. Front Oncol. 2020; 10:1179. Vitzthum LK, Heide ES, Park H, Williamson CW, Sheridan P, Huynh-Le MP, Sirak I, Wei L, Tarnawski R, Mahantshetty U, Nguyen C, Mayadev J, Yashar CM, Sacco AG, Mell LK. PMID: 32793487; PMCID: PMC7385402.
      View in: PubMed   Mentions: 5  
    56. To Intensify or Not to Intensify? Consideration of Competing Risks in the Management of Locoregionally Advanced p16+ Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys. 2020 07 15; 107(4):613-614. Simon AB, Mell LK. PMID: 32589985.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 Trial. Int J Radiat Oncol Biol Phys. 2020 12 01; 108(5):1240-1247. Yusufaly T, Miller A, Medina-Palomo A, Williamson CW, Nguyen H, Lowenstein J, Leath CA, Xiao Y, Moore KL, Moxley KM, Chevere-Mourino CM, Eng TY, Zaid T, Mell LK. PMID: 32629079; PMCID: PMC7944643.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    58. Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 07; 18(7):873-898. Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM, Bruce JY, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Galloway T, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco JW, Rodriguez CP, Shah JP, Weber RS, Weinstein G, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD. PMID: 32634781.
      View in: PubMed   Mentions: 410     Fields:    Translation:Humans
    59. Predicting Persistent Opioid Use, Abuse, and Toxicity Among Cancer Survivors. J Natl Cancer Inst. 2020 07 01; 112(7):720-727. Vitzthum LK, Riviere P, Sheridan P, Nalawade V, Deka R, Furnish T, Mell LK, Rose B, Wallace M, Murphy JD. PMID: 31754696; PMCID: PMC7357328.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    60. A knowledge-based organ dose prediction tool for brachytherapy treatment planning of patients with cervical cancer. Brachytherapy. 2020 Sep - Oct; 19(5):624-634. Yusufaly TI, Kallis K, Simon A, Mayadev J, Yashar CM, Einck JP, Mell LK, Brown D, Scanderbeg D, Hild SJ, Covele B, Moore KL, Meyers SM. PMID: 32513446.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    61. Phase 1 Trial of Concurrent Gemcitabine and Cisplatin with Image Guided Intensity Modulated Radiation Therapy for Locoregionally Advanced Cervical Carcinoma. Int J Radiat Oncol Biol Phys. 2020 08 01; 107(5):964-973. Mell LK, Xu R, Yashar CM, McHale MT, Einck JP, Mayadev J, Lee E, Binder P, Rash D, Eskander R, Heide ES, Plaxe SC, Mundt AJ, Saenz CC. PMID: 32334034; PMCID: PMC9440640.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    62. Challenge of Directly Comparing Imaging-Based Diagnoses Made by Machine Learning Algorithms With Those Made by Human Clinicians. J Clin Oncol. 2020 06 01; 38(16):1868-1869. Simon AB, Vitzthum LK, Mell LK. PMID: 32271670; PMCID: PMC7255980.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    63. B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade. Clin Cancer Res. 2020 07 01; 26(13):3345-3359. Kim SS, Shen S, Miyauchi S, Sanders PD, Franiak-Pietryga I, Mell L, Gutkind JS, Cohen EEW, Califano JA, Sharabi AB. PMID: 32193227; PMCID: PMC7334097.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimalsCells
    64. Implementation of peer-review quality rounds for gynecologic brachytherapy in a high-volume academic center. Brachytherapy. 2020 Nov - Dec; 19(6):881-888. Huynh-Le MP, Simon AB, Hoopes DJ, Einck JP, Yashar CM, Scanderbeg D, Rash D, Brown D, Mell LK, Sanghvi PR, Mundt AJ, Pawlicki T, Mayadev JS. PMID: 31917179.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    65. Risk of Pelvic Fracture With Radiation Therapy in Older Patients. Int J Radiat Oncol Biol Phys. 2020 03 01; 106(3):485-492. Vitzthum LK, Park H, Zakeri K, Heide ES, Nalawade V, Mundt AJ, Vaida F, Murphy JD, Mell LK. PMID: 31610251; PMCID: PMC8906845.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    66. Selection of Head and Neck Cancer Patients for Intensive Therapy. Int J Radiat Oncol Biol Phys. 2020 01 01; 106(1):157-166. Vitzthum LK, Park H, Zakeri K, Bryant AK, Feng C, Shen H, Cohen EEW, Murphy JD, Mell LK. PMID: 31580929.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    67. Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer. Clin Cancer Res. 2019 12 01; 25(23):7078-7088. Mell LK, Shen H, Nguyen-Tân PF, Rosenthal DI, Zakeri K, Vitzthum LK, Frank SJ, Schiff PB, Trotti AM, Bonner JA, Jones CU, Yom SS, Thorstad WL, Wong SJ, Shenouda G, Ridge JA, Zhang QE, Le QT. PMID: 31420360; PMCID: PMC7028339.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    68. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC). J Immunother Cancer. 2019 07 15; 7(1):184. Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, Uppaluri R, Whitworth F, Zandberg DP, Ferris RL. PMID: 31307547; PMCID: PMC6632213.
      View in: PubMed   Mentions: 258     Fields:    Translation:HumansCTClinical Trials
    69. Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer. Brachytherapy. 2019 Sep - Oct; 18(5):612-619. Huynh-Le MP, Klapheke A, Cress R, Mell LK, Yashar CM, Einck JP, Mundt AJ, Mayadev JS. PMID: 31153760.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    70. Undertreatment of women with locoregionally advanced head and neck cancer. Cancer. 2019 09 01; 125(17):3033-3039. Park A, Alabaster A, Shen H, Mell LK, Katzel JA. PMID: 31090932.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    71. The Impact of Surgeons on the Likelihood of Mastectomy in Breast Cancer. Ann Surg. 2019 05; 269(5):951-958. Boero IJ, Paravati AJ, Hou J, Gillespie EF, Schoenbrunner A, Unkart J, Wallace AM, Einck JP, Mell LK, Murphy JD. PMID: 29465454.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    72. Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion. J Clin Oncol. 2019 06 20; 37(18):1578-1589. Adelstein DJ, Ismaila N, Ku JA, Burtness B, Swiecicki PL, Mell L, Beitler JJ, Gross N, Jones CU, Kaufman M, Le QT, Semrad TJ, Siu LL, Ridge JA. PMID: 31021656.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    73. Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics. Clin Cancer Res. 2019 07 15; 25(14):4211-4223. Miyauchi S, Kim SS, Pang J, Gold KA, Gutkind JS, Califano JA, Mell LK, Cohen EEW, Sharabi AB. PMID: 30814108; PMCID: PMC6635035.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansAnimals
    74. Detecting a Survival Benefit to Dose Escalation. JAMA Oncol. 2019 01 01; 5(1):109-110. Zakeri K, Rose BS, Mell LK. PMID: 30452492.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    75. Generalized Competing Event Models Can Reduce Cost and Duration of Cancer Clinical Trials. JCO Clin Cancer Inform. 2018 12; 2:1-12. Zakeri K, Panjwani N, Carmona R, Shen H, Vitzthum LK, Zhang QE, Murphy JD, Mell LK. PMID: 30652559.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    76. Comparison of Comorbidity and Frailty Indices in Patients With Head and Neck Cancer Using an Online Tool. JCO Clin Cancer Inform. 2018 12; 2:1-9. Vitzthum LK, Feng CH, Noticewala S, Hines PJ, Nguyen C, Zakeri K, Sojourner EJ, Shen H, Mell LK. PMID: 30652602.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    77. Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer. J Natl Cancer Inst. 2018 12 01; 110(12):1393-1399. Bryant AK, Sojourner EJ, Vitzthum LK, Zakeri K, Shen H, Nguyen C, Murphy JD, Califano JA, Cohen EEW, Mell LK. PMID: 29878161; PMCID: PMC6292787.
      View in: PubMed   Mentions: 25     Fields:    
    78. Incidence of Long-Term Esophageal Dilation With Various Treatment Approaches in the Older Head and Neck Cancer Population. Front Oncol. 2018; 8:466. Green G, Kim E, Carmona R, Shen H, Murphy JD, Mell LK. PMID: 30406032; PMCID: PMC6206230.
      View in: PubMed   Mentions:
    79. Radiation Therapy Combined With Checkpoint Blockade Immunotherapy for Metastatic Undifferentiated Pleomorphic Sarcoma of the Maxillary Sinus With a Complete Response. Front Oncol. 2018; 8:435. Guram K, Nunez M, Einck J, Mell LK, Cohen E, Sanders PD, Miyauchi S, Weihe E, Kurzrock R, Boles S, Sharabi AB. PMID: 30386736; PMCID: PMC6199376.
      View in: PubMed   Mentions: 12  
    80. 'Optimism bias' in contemporary national clinical trial network phase III trials: are we improving? Ann Oncol. 2018 10 01; 29(10):2135-2139. Zakeri K, Noticewala S, Vitzthum L, Sojourner E, Shen H, Mell L. PMID: 30412223; PMCID: PMC6454418.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    81. The role of p16 as a biomarker in nonoropharyngeal head and neck cancer. Oncotarget. 2018 Sep 07; 9(70):33247-33248. Vitzthum LK, Mell LK. PMID: 30279955; PMCID: PMC6161792.
      View in: PubMed   Mentions: 5     Fields:    
    82. Intensity Modulated Radiation Therapy Versus Conventional Radiation for Anal Cancer in the Veterans Affairs System. Int J Radiat Oncol Biol Phys. 2018 09 01; 102(1):109-115. Bryant AK, Huynh-Le MP, Simpson DR, Mell LK, Gupta S, Murphy JD. PMID: 30102186.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    83. NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. J Natl Compr Canc Netw. 2018 05; 16(5):479-490. Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD. PMID: 29752322.
      View in: PubMed   Mentions: 221     Fields:    Translation:Humans
    84. Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California. Gynecol Oncol. 2018 07; 150(1):73-78. Mayadev J, Klapheke A, Yashar C, Hsu IC, Kamrava M, Mundt AJ, Mell LK, Einck J, Benedict S, Valicenti R, Cress R. PMID: 29709291.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    85. Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1188-1193. Bryant AK, Kader AK, McKay RR, Einck JP, Mell LK, Mundt AJ, Kane CJ, Efstathiou JA, Murphy JD, Rose BS. PMID: 29891203.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    86. The impact of daily bladder filling on small bowel dose for intensity modulated radiation therapy for cervical cancer. Med Dosim. 2019 Summer; 44(2):102-106. Chen VE, Gillespie EF, Manger RP, Skerritt LA, Tran JH, Proudfoot JA, Sherer MV, Einck JP, Mell LK, Moore KL, Yashar CM. PMID: 29573921.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    87. Effect of CD4 Count on Treatment Toxicity and Tumor Recurrence in Human Immunodeficiency Virus-Positive Patients With Anal Cancer. Int J Radiat Oncol Biol Phys. 2018 02 01; 100(2):478-485. Bryant AK, Mudgway R, Huynh-Le MP, Simpson DR, Mell LK, Gupta S, Sharabi AB, Murphy JD. PMID: 29102276.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    88. Phase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma. Clin Cancer Res. 2017 Oct 01; 23(19):5696-5702. Mell LK, Brumund KT, Daniels GA, Advani SJ, Zakeri K, Wright ME, Onyeama SJ, Weisman RA, Sanghvi PR, Martin PJ, Szalay AA. PMID: 28679776.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCellsCTClinical Trials
    89. In Reply to Singh. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):483-484. INTERTECC Study Group, Mell LK, Sirák I, Mahantshetty U. PMID: 28463171.
      View in: PubMed   Mentions:    Fields:    
    90. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017. J Natl Compr Canc Netw. 2017 06; 15(6):761-770. Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD. PMID: 28596256.
      View in: PubMed   Mentions: 128     Fields:    Translation:Humans
    91. Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer. Radiother Oncol. 2017 05; 123(2):325-330. Li N, Noticewala SS, Williamson CW, Shen H, Sirak I, Tarnawski R, Mahantshetty U, Hoh CK, Moore KL, Mell LK. PMID: 28528206.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    92. Defining Prognostic Biomarkers and Optimal Adjuvant Treatment for Gynecologic Cancer. Int J Radiat Oncol Biol Phys. 2017 05 01; 98(1):1-4. Beriwal S, Klopp A, Mell L. PMID: 28586944.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    93. Trends in Radiation Therapy among Cancer Survivors in the United States, 2000-2030. Cancer Epidemiol Biomarkers Prev. 2017 06; 26(6):963-970. Bryant AK, Banegas MP, Martinez ME, Mell LK, Murphy JD. PMID: 28096199.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    94. Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. 2017 03 15; 97(4):797-805. Noticewala SS, Li N, Williamson CW, Hoh CK, Shen H, McHale MT, Saenz CC, Einck J, Plaxe S, Vaida F, Yashar CM, Mell LK. PMID: 28244416.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    95. Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2). Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):536-545. Mell LK, Sirák I, Wei L, Tarnawski R, Mahantshetty U, Yashar CM, McHale MT, Xu R, Honerkamp-Smith G, Carmona R, Wright M, Williamson CW, Kasaová L, Li N, Kry S, Michalski J, Bosch W, Straube W, Schwarz J, Lowenstein J, Jiang SB, Saenz CC, Plaxe S, Einck J, Khorprasert C, Koonings P, Harrison T, Shi M, Mundt AJ, INTERTECC Study Group. PMID: 28126303.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCTClinical Trials
    96. The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer. Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):571-580. Boero IJ, Gillespie EF, Hou J, Paravati AJ, Kim E, Einck JP, Yashar C, Mell LK, Murphy JD. PMID: 28126306.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    97. Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer. J Clin Oncol. 2016 11 10; 34(32):3886-3891. Acevedo JR, Fero KE, Wilson B, Sacco AG, Mell LK, Coffey CS, Murphy JD. PMID: 27551113; PMCID: PMC5457359.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    98. Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials. Int J Radiat Oncol Biol Phys. 2017 01 01; 97(1):164-172. Li N, Carmona R, Sirak I, Kasaova L, Followill D, Michalski J, Bosch W, Straube W, Mell LK, Moore KL. PMID: 27979445; PMCID: PMC5175211.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    99. Progress in Vulvar and Endometrial Cancers: Exploiting Anatomy and Biology and Improving Systemic Therapy. Int J Radiat Oncol Biol Phys. 2016 09 01; 96(1):1-5. Yashar CM, Beriwal S, Klopp A, Mell L. PMID: 27511840.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    100. Prospective Validation of a High Dimensional Shape Model for Organ Motion in Intact Cervical Cancer. Int J Radiat Oncol Biol Phys. 2016 11 15; 96(4):801-807. Williamson CW, Green G, Noticewala SS, Li N, Shen H, Vaida F, Mell LK. PMID: 27788953; PMCID: PMC6369704.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    101. Specificity of Genetic Biomarker Studies in Cancer Research: A Systematic Review. PLoS One. 2016; 11(7):e0156489. Green G, Carmona R, Zakeri K, Lee CH, Borgan S, Marhoon Z, Sharabi A, Mell LK. PMID: 27383192; PMCID: PMC4934683.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    102. Patterns of Palliative Care Consultation Among Elderly Patients With Cancer. J Natl Compr Canc Netw. 2016 04; 14(4):439-45. Roeland EJ, Triplett DP, Matsuno RK, Boero IJ, Hwang L, Yeung HN, Mell L, Murphy JD. PMID: 27059192.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    103. An Automated Treatment Plan Quality Control Tool for Intensity-Modulated Radiation Therapy Using a Voxel-Weighting Factor-Based Re-Optimization Algorithm. PLoS One. 2016; 11(3):e0149273. Song T, Li N, Zarepisheh M, Li Y, Gautier Q, Zhou L, Mell L, Jiang S, Cerviño L. PMID: 26930204; PMCID: PMC4773182.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    104. Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events. J Clin Oncol. 2016 Apr 10; 34(11):1270-7. Carmona R, Zakeri K, Green G, Hwang L, Gulaya S, Xu B, Verma R, Williamson CW, Triplett DP, Rose BS, Shen H, Vaida F, Murphy JD, Mell LK. PMID: 26884579; PMCID: PMC5070568.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    105. Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study. Am J Clin Oncol. 2016 Feb; 39(1):8-12. Call JA, Prendergast BM, Jensen LG, Ord CB, Goodman KA, Jacob R, Mell LK, Thomas CR, Jabbour SK, Miller RC. PMID: 24401669; PMCID: PMC10865428.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    106. Radiation sparing of cerebral cortex in brain tumor patients using quantitative neuroimaging. Radiother Oncol. 2016 Jan; 118(1):29-34. Karunamuni RA, Moore KL, Seibert TM, Li N, White NS, Bartsch H, Carmona R, Marshall D, McDonald CR, Farid N, Krishnan A, Kuperman J, Mell LK, Brewer J, Dale AM, Moiseenko V, Hattangadi-Gluth JA. PMID: 26806266; PMCID: PMC4764402.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    107. Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy. J Clin Oncol. 2016 Mar 01; 34(7):684-90. Boero IJ, Paravati AJ, Xu B, Cohen EE, Mell LK, Le QT, Murphy JD. PMID: 26729432; PMCID: PMC4872027.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    108. Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer. Int J Radiat Oncol Biol Phys. 2016 Mar 15; 94(4):700-8. Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Gillespie EF, Yashar CM, Moiseenko V, Einck JP, Mell LK, Parikh SA, Murphy JD. PMID: 26972642.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    109. [(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients. Radiother Oncol. 2016 Jan; 118(1):72-8. Wyss JC, Carmona R, Karunamuni RA, Pritz J, Hoh CK, Mell LK. PMID: 26674924; PMCID: PMC4764473.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    110. Dose-Dependent Cortical Thinning After Partial Brain Irradiation in High-Grade Glioma. Int J Radiat Oncol Biol Phys. 2016 Feb 01; 94(2):297-304. Karunamuni R, Bartsch H, White NS, Moiseenko V, Carmona R, Marshall DC, Seibert TM, McDonald CR, Farid N, Krishnan A, Kuperman J, Mell L, Brewer JB, Dale AM, Hattangadi-Gluth JA. PMID: 26853338; PMCID: PMC4747044.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    111. The impact of radiotherapy costs on clinical outcomes in breast cancer. Radiother Oncol. 2015 Nov; 117(2):393-9. Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Mell LK, Murphy JD. PMID: 26472317; PMCID: PMC4758206.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    112. Cultivating Future Clinician Scientists: In Regard to Vapiwala et al. Int J Radiat Oncol Biol Phys. 2015 Oct 01; 93(2):468. Mell LK. PMID: 26383687.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    113. Variation in the Cost of Radiation Therapy Among Medicare Patients With Cancer. J Oncol Pract. 2015 Sep; 11(5):403-9. Paravati AJ, Boero IJ, Triplett DP, Hwang L, Matsuno RK, Xu B, Mell LK, Murphy JD. PMID: 26265172; PMCID: PMC4575405.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    114. Underrepresentation of Local Therapy Trials in Leading Medical Journals: Cause for Outrage or Indifference? Int J Radiat Oncol Biol Phys. 2015 Jul 15; 92(4):732-4. Mell LK, Zakeri K. PMID: 26104928.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    115. Head and Neck Cancers, Version 1.2015. J Natl Compr Canc Netw. 2015 Jul; 13(7):847-55; quiz 856. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M. PMID: 26150579; PMCID: PMC4976490.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    116. Dosimetric benefit of adaptive re-planning in pancreatic cancer stereotactic body radiotherapy. Med Dosim. 2015; 40(4):318-24. Li Y, Hoisak JD, Li N, Jiang C, Tian Z, Gautier Q, Zarepisheh M, Wu Z, Liu Y, Jia X, Hattangadi-Gluth J, Mell LK, Jiang S, Murphy JD. PMID: 26002122.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    117. Clinical Outcomes of Computed Tomography-Based Volumetric Brachytherapy Planning for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):150-7. Simpson DR, Scanderbeg DJ, Carmona R, McMurtrie RM, Einck J, Mell LK, McHale MT, Saenz CC, Plaxe SC, Harrison T, Mundt AJ, Yashar CM. PMID: 26130230.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    118. Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer. Radiother Oncol. 2015 Apr; 115(1):114-9. Zakeri K, Rose BS, D'Amico AV, Jeong JH, Mell LK. PMID: 25857696.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    119. Longitudinal study of acute haematologic toxicity in cervical cancer patients treated with chemoradiotherapy. J Med Imaging Radiat Oncol. 2015 Jun; 59(3):386-93; quiz 394. Zhu H, Zakeri K, Vaida F, Carmona R, Dadachanji KK, Bair R, Aydogan B, Hasan Y, Yashar CM, Mell LK. PMID: 25828068; PMCID: PMC6373449.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    120. A deformable head and neck phantom with in-vivo dosimetry for adaptive radiotherapy quality assurance. Med Phys. 2015 Apr; 42(4):1490-7. Graves YJ, Smith AA, Mcilvena D, Manilay Z, Lai YK, Rice R, Mell L, Jia X, Jiang SB, Cerviño L. PMID: 25832039.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    121. A blast from the past and foresight for the future of gynecologic oncology. Int J Radiat Oncol Biol Phys. 2015 Apr 01; 91(5):885-7. Yashar C, Beriwal S, Mell L, Klopp A. PMID: 25832680.
      View in: PubMed   Mentions:    Fields:    
    122. A segmentation and point-matching enhanced efficient deformable image registration method for dose accumulation between HDR CT images. Phys Med Biol. 2015 Apr 07; 60(7):2981-3002. Zhen X, Chen H, Yan H, Zhou L, Mell LK, Yashar CM, Jiang S, Jia X, Gu X, Cervino L. PMID: 25790059.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    123. Angiotensin-converting enzyme inhibitors predict acute kidney injury during chemoradiation for head and neck cancer. Anticancer Drugs. 2015 Mar; 26(3):343-9. Spiotto MT, Cao H, Mell L, Toback FG. PMID: 25486599; PMCID: PMC4310759.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    124. Survival in unresectable sinonasal undifferentiated carcinoma treated with concurrent intra-arterial cisplatin and radiation. World J Clin Cases. 2015 Feb 16; 3(2):191-5. Noticewala SS, Mell LK, Olson SE, Read W. PMID: 25685767; PMCID: PMC4317614.
      View in: PubMed   Mentions: 1  
    125. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer. Cancer. 2015 Apr 15; 121(8):1303-11. Xu B, Boero IJ, Hwang L, Le QT, Moiseenko V, Sanghvi PR, Cohen EE, Mell LK, Murphy JD. PMID: 25537836; PMCID: PMC4774546.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    126. Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck. Oral Oncol. 2015 Apr; 51(4):291-8. Simpson DR, Mell LK, Cohen EE. PMID: 25532816.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    127. Introducing prospective manuscript review to address publication bias. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):729-32. Mell LK, Zietman AL. PMID: 25585776.
      View in: PubMed   Mentions: 5     Fields:    
    128. Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014 Oct; 12(10):1454-87. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M, National Comprehensive Cancer Network. PMID: 25313184.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    129. Age disparity in palliative radiation therapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys. 2014 Sep 01; 90(1):224-30. Wong J, Xu B, Yeung HN, Roeland EJ, Martinez ME, Le QT, Mell LK, Murphy JD. PMID: 25195994; PMCID: PMC4187217.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    130. Validated competing event model for the stage I-II endometrial cancer population. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):888-98. Carmona R, Gulaya S, Murphy JD, Rose BS, Wu J, Noticewala S, McHale MT, Yashar CM, Vaida F, Mell LK. PMID: 24969798; PMCID: PMC8783697.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    131. Fat composition changes in bone marrow during chemotherapy and radiation therapy. Int J Radiat Oncol Biol Phys. 2014 Sep 01; 90(1):155-63. Carmona R, Pritz J, Bydder M, Gulaya S, Zhu H, Williamson CW, Welch CS, Vaida F, Bydder G, Mell LK. PMID: 25015207; PMCID: PMC4159416.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    132. Palliative radiation before hospice: the long and the short of it. J Pain Symptom Manage. 2014 Dec; 48(6):1070-9. Yeung HN, Mitchell WM, Roeland EJ, Xu B, Mell LK, Le QT, Murphy JD. PMID: 24819083.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    133. Proton density water fraction as a biomarker of bone marrow cellularity: validation in ex vivo spine specimens. Magn Reson Imaging. 2014 Nov; 32(9):1097-101. MacEwan IJ, Glembotski NE, D'Lima D, Bae W, Masuda K, Rashidi HH, Mell LK, Bydder M. PMID: 25240720.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    134. On lumping, splitting, and the nosology of clinical trial populations and end points. J Clin Oncol. 2014 Apr 01; 32(10):1089-90. Mell LK, Zakeri K, Rose BS. PMID: 24550413.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    135. Automatic treatment plan re-optimization for adaptive radiotherapy guided with the initial plan DVHs. Phys Med Biol. 2013 Dec 21; 58(24):8725-38. Li N, Zarepisheh M, Uribe-Sanchez A, Moore K, Tian Z, Zhen X, Graves YJ, Gautier Q, Mell L, Zhou L, Jia X, Jiang S. PMID: 24301071.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    136. Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer. J Natl Cancer Inst. 2013 Dec 04; 105(23):1814-20. Simpson DR, Martínez ME, Gupta S, Hattangadi-Gluth J, Mell LK, Heestand G, Fanta P, Ramamoorthy S, Le QT, Murphy JD. PMID: 24231453; PMCID: PMC4383284.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    137. Race and competing mortality in advanced head and neck cancer. Oral Oncol. 2014 Jan; 50(1):40-4. Zakeri K, MacEwan I, Vazirnia A, Cohen EE, Spiotto MT, Haraf DJ, Vokes EE, Weichselbaum RR, Mell LK. PMID: 24134948.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    138. Cause-specific effects of radiotherapy and lymphadenectomy in stage I-II endometrial cancer: a population-based study. J Natl Cancer Inst. 2013 Nov 06; 105(21):1656-66. Mell LK, Carmona R, Gulaya S, Lu T, Wu J, Saenz CC, Vaida F. PMID: 24123960; PMCID: PMC6281051.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    139. Oncology scan - gynecological cancers: new treatments, old treatments, imaging, and meta-analyses. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):207-10. Mundt AJ, Yashar C, Mell L, Mayr N, Milosevic M. PMID: 23643375.
      View in: PubMed   Mentions:    Fields:    
    140. Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis. Am J Clin Oncol. 2013 Jun; 36(3):269-72. Pan H, Rose BS, Simpson DR, Mell LK, Mundt AJ, Lawson JD. PMID: 22495454; PMCID: PMC3396796.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    141. Patterns of care in palliative radiotherapy: a population-based study. J Oncol Pract. 2013 Sep; 9(5):e220-7. Murphy JD, Nelson LM, Chang DT, Mell LK, Le QT. PMID: 23943892.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    142. Feasibility study on dosimetry verification of volumetric-modulated arc therapy-based total marrow irradiation. J Appl Clin Med Phys. 2013 Mar 04; 14(2):3852. Liang Y, Kim GY, Pawlicki T, Mundt AJ, Mell LK. PMID: 23470926; PMCID: PMC5714362.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    143. A contour-guided deformable image registration algorithm for adaptive radiotherapy. Phys Med Biol. 2013 Mar 21; 58(6):1889-901. Gu X, Dong B, Wang J, Yordy J, Mell L, Jia X, Jiang SB. PMID: 23442596.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    144. Outcomes for patients with cervical cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin. Int J Gynecol Cancer. 2013 Jan; 23(1):119-25. Jensen LG, Hasselle MD, Rose BS, Nath SK, Hasan Y, Scanderbeg DJ, Yashar CM, Mundt AJ, Mell LK. PMID: 23262521.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    145. Intensity modulated radiation therapy for gynecologic malignancies: a testable hypothesis. Int J Radiat Oncol Biol Phys. 2012 Nov 01; 84(3):566-8. Mell LK. PMID: 22999264.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    146. Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794. Contemp Clin Trials. 2013 Jan; 34(1):74-9. Zakeri K, Rose BS, Gulaya S, D'Amico AV, Mell LK. PMID: 23063467; PMCID: PMC3525784.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    147. Liver motion during cone beam computed tomography guided stereotactic body radiation therapy. Med Phys. 2012 Oct; 39(10):6431-42. Park JC, Park SH, Kim JH, Yoon SM, Song SY, Liu Z, Song B, Kauweloa K, Webster MJ, Sandhu A, Mell LK, Jiang SB, Mundt AJ, Song WY. PMID: 23039678.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    148. The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy. Cancer. 2013 Jan 15; 119(2):325-31. Song S, Rudra S, Hasselle MD, Dorn PL, Mell LK, Mundt AJ, Yamada SD, Lee NK, Hasan Y. PMID: 22806897.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    149. Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):406-14. Liang Y, Bydder M, Yashar CM, Rose BS, Cornell M, Hoh CK, Lawson JD, Einck J, Saenz C, Fanta P, Mundt AJ, Bydder GM, Mell LK. PMID: 22687195.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    150. Reporting of cause-specific treatment effects in cancer clinical trials with competing risks: a systematic review. Contemp Clin Trials. 2012 Sep; 33(5):920-4. Mell LK, Lau SK, Rose BS, Jeong JH. PMID: 22664646.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    151. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):e81-6. Simpson DR, Song WY, Moiseenko V, Rose BS, Yashar CM, Mundt AJ, Mell LK. PMID: 22516388.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    152. Optimized planning target volume for intact cervical cancer. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1500-5. Khan A, Jensen LG, Sun S, Song WY, Yashar CM, Mundt AJ, Zhang FQ, Jiang SB, Mell LK. PMID: 22270167.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    153. Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):1185-91. Rose BS, Liang Y, Lau SK, Jensen LG, Yashar CM, Hoh CK, Mell LK. PMID: 22270171.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    154. Population-based study of competing mortality in head and neck cancer. J Clin Oncol. 2011 Sep 10; 29(26):3503-9. Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK. PMID: 21844503.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    155. A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy. Radiat Oncol. 2011 Jun 06; 6:61. Moiseenko V, Song WY, Mell LK, Bhandare N. PMID: 21645390; PMCID: PMC3127783.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    156. How does TPF improve survival over PF? Lancet Oncol. 2011 May; 12(5):419-20; author reply 421-2. Devisetty K, Wong SJ, Mell LK. PMID: 21536218.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    157. A survey of stereotactic body radiotherapy use in the United States. Cancer. 2011 Oct 01; 117(19):4566-72. Pan H, Simpson DR, Mell LK, Mundt AJ, Lawson JD. PMID: 21412761; PMCID: PMC3142290.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    158. Daily online cone beam computed tomography to assess interfractional motion in patients with intact cervical cancer. Int J Radiat Oncol Biol Phys. 2011 May 01; 80(1):273-80. Tyagi N, Lewis JH, Yashar CM, Vo D, Jiang SB, Mundt AJ, Mell LK. PMID: 21109360.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    159. Predictors of competing mortality in early breast cancer. Cancer. 2010 Dec 01; 116(23):5365-73. Mell LK, Jeong JH, Nichols MA, Polite BN, Weichselbaum RR, Chmura SJ. PMID: 20737562.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    160. Pitfalls of using composite primary end points in the presence of competing risks. J Clin Oncol. 2010 Oct 01; 28(28):4297-9. Mell LK, Jeong JH. PMID: 20713860.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    161. A survey of image-guided radiation therapy use in the United States. Cancer. 2010 Aug 15; 116(16):3953-60. Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell LK. PMID: 20564090; PMCID: PMC2919592.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    162. Dosimetric comparison study between intensity modulated radiation therapy and three-dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer. J Appl Clin Med Phys. 2010 Aug 15; 11(4):3255. Song WY, Huh SN, Liang Y, White G, Nichols RC, Watkins WT, Mundt AJ, Mell LK. PMID: 21081882; PMCID: PMC5720421.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    163. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1436-45. Hasselle MD, Rose BS, Kochanski JD, Nath SK, Bafana R, Yashar CM, Hasan Y, Roeske JC, Mundt AJ, Mell LK. PMID: 20708346.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    164. Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):912-9. Liang Y, Messer K, Rose BS, Lewis JH, Jiang SB, Yashar CM, Mundt AJ, Mell LK. PMID: 20472344; PMCID: PMC2923677.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    165. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys. 2011 Feb 01; 79(2):348-55. Lim K, Small W, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A, Gyn IMRT Consortium. PMID: 20472347.
      View in: PubMed   Mentions: 131     Fields:    Translation:Humans
    166. Outcomes in black patients with early breast cancer treated with breast conservation therapy. Int J Radiat Oncol Biol Phys. 2011 Feb 01; 79(2):392-9. Nichols MA, Mell LK, Hasselle MD, Karrison TG, MacDermed D, Meriwether A, Witt ME, Weichselbaum RR, Chmura SJ. PMID: 20434849.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    167. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):800-7. Rose BS, Aydogan B, Liang Y, Yeginer M, Hasselle MD, Dandekar V, Bafana R, Yashar CM, Mundt AJ, Roeske JC, Mell LK. PMID: 20400238; PMCID: PMC2907446.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCellsPHPublic Health
    168. Utilization of advanced imaging technologies for target delineation in radiation oncology. J Am Coll Radiol. 2009 Dec; 6(12):876-83. Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell LK. PMID: 19945044.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    169. Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol. 2010 Jan 01; 28(1):15-20. Mell LK, Dignam JJ, Salama JK, Cohen EE, Polite BN, Dandekar V, Bhate AD, Witt ME, Haraf DJ, Mittal BB, Vokes EE, Weichselbaum RR. PMID: 19933920.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    170. A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol. 2009 Nov; 93(2):298-301. Devisetty K, Mell LK, Salama JK, Schomas DA, Miller RC, Jani AB, Roeske JC, Aydogan B, Chmura SJ. PMID: 19717198.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    171. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer. 2008 Nov 01; 113(9):2408-14. Al-Hallaq HA, Mell LK, Bradley JA, Chen LF, Ali AN, Weichselbaum RR, Newstead GM, Chmura SJ. PMID: 18823018.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    172. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2008 Oct; 134(10):1060-5. Salama JK, Stenson KM, List MA, Mell LK, Maccracken E, Cohen EE, Blair E, Vokes EE, Haraf DJ. PMID: 18936351.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    173. Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine. Expert Opin Drug Metab Toxicol. 2008 Oct; 4(10):1341-50. Mell LK, Movsas B. PMID: 18798703.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    174. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2008 Aug 01; 71(5):1504-10. Mell LK, Tiryaki H, Ahn KH, Mundt AJ, Roeske JC, Aydogan B. PMID: 18640499.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    175. Intensity-modulated radiation therapy in gynecologic cancers: growing support, growing acceptance. Cancer J. 2008 May-Jun; 14(3):198-9. Mell LK, Mundt AJ. PMID: 18536560.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    176. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys. 2008 Jun 01; 71(2):428-34. Small W, Mell LK, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, Jhingran A, Portelance L, Schefter T, Iyer R, Varia M, Winter K, Mundt AJ. PMID: 18037584; PMCID: PMC2752724.
      View in: PubMed   Mentions: 119     Fields:    Translation:Humans
    177. More on cetuximab in head and neck cancer. N Engl J Med. 2007 Nov 22; 357(21):2201-2; author reply 2202-3. Mell LK, Weichselbaum RR. PMID: 18032774.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    178. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Apr 01; 70(5):1431-7. Mell LK, Schomas DA, Salama JK, Devisetty K, Aydogan B, Miller RC, Jani AB, Kindler HL, Mundt AJ, Roeske JC, Chmura SJ. PMID: 17996390.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    179. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol. 2007 Oct 10; 25(29):4581-6. Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ. PMID: 17925552.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    180. Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: a meta-analysis. Int J Radiat Oncol Biol Phys. 2007 May 01; 68(1):111-8. Mell LK, Malik R, Komaki R, Movsas B, Swann RS, Langer C, Antonadou D, Koukourakis M, Mundt AJ. PMID: 17289291.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    181. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Dec 01; 66(5):1356-65. Mell LK, Kochanski JD, Roeske JC, Haslam JJ, Mehta N, Yamada SD, Hurteau JA, Collins YC, Lengyel E, Mundt AJ. PMID: 16757127.
      View in: PubMed   Mentions: 122     Fields:    Translation:Humans
    182. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients. Int J Radiat Oncol Biol Phys. 2006 May 01; 65(1):266-73. Aydogan B, Mundt AJ, Smith BD, Mell LK, Wang S, Sutton H, Roeske JC. PMID: 16618581.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    183. Intensity-modulated radiation therapy in gynecologic malignancies: current status and future directions. Clin Adv Hematol Oncol. 2006 May; 4(5):379-86. Kochanski JD, Mell LK, Roeske JC, Mundt AJ. PMID: 16728946.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    184. Radiation therapy in the elderly. Cancer J. 2005 Nov-Dec; 11(6):495-505. Mell LK, Mundt AJ. PMID: 16393484.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    185. Intensity-modulated radiation therapy use in the U.S., 2004. Cancer. 2005 Sep 15; 104(6):1296-303. Mell LK, Mehrotra AK, Mundt AJ. PMID: 16078260.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    186. Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics. 2005 Jul; 116(1):56-60. Mell LK, Davis RL, Owens D. PMID: 15995031.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCells
    187. Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients. Int J Radiat Oncol Biol Phys. 2005 Mar 15; 61(4):1078-86. Schroder M, Mell LK, Hurteau JA, Collins YC, Rotmensch J, Waggoner SE, Yamada SD, Small W, Mundt AJ. PMID: 15752887.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    188. Compliance with national immunization guidelines for children younger than 2 years, 1996-1999. Pediatrics. 2005 Feb; 115(2):461-7. Mell LK, Ogren DS, Davis RL, Mullooly JP, Black SB, Shinefield HR, Zangwill KM, Ward JI, Marcy SM, Chen RT, Centers for Disease Control and Prevention Vaccine Safety Datalink Project. PMID: 15687456.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    189. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer. Clin Cancer Res. 2004 Aug 15; 10(16):5546-53. Mell LK, Meyer JJ, Tretiakova M, Khramtsov A, Gong C, Yamada SD, Montag AG, Mundt AJ. PMID: 15328195.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    190. Intensity-modulated radiotherapy and the Internet. Cancer. 2004 Jul 15; 101(2):412-20. Schomas DA, Milano MT, Roeske JC, Mell LK, Mundt AJ. PMID: 15241841.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    191. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Radiother Oncol. 2003 Nov; 69(2):201-7. Roeske JC, Bonta D, Mell LK, Lujan AE, Mundt AJ. PMID: 14643959.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    192. Concern with "Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?". Gynecol Oncol. 2003 Aug; 90(2):499; author reply 499-500. Mell LK, Mundt AJ. PMID: 12893236.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    193. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys. 2003 Aug 01; 56(5):1354-60. Mundt AJ, Mell LK, Roeske JC. PMID: 12873680.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    194. A survey of intensity-modulated radiation therapy use in the United States. Cancer. 2003 Jul 01; 98(1):204-11. Mell LK, Roeske JC, Mundt AJ. PMID: 12833473.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    195. Impact of the introduction of a combined Haemophilus B conjugate vaccine and hepatitis B recombinant vaccine on vaccine coverage rats in a large West Coast health maintenance organization. Pediatr Infect Dis J. 2003 Jul; 22(7):657-8. Davis RL, Coplan P, Mell L, Black S, Shinefield H, Lewis E. PMID: 12886895.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    196. Polio extraimmunization in children younger than 2 years after changes in immunization recommendations. Pediatrics. 2003 Feb; 111(2):296-301. Mell LK, Davis RL, Mullooly JP, Black SB, Shinefield HR, Zangwill KM, Ward JI, Marcy SM, Chen RT, CDC Vaccine Safety Datalink Project. PMID: 12563054.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    197. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder. Pediatrics. 2002 May; 109(5):733-9. Guevara J, Lozano P, Wickizer T, Mell L, Gephart H. PMID: 11986429.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    198. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics. 2001 Jul; 108(1):71-8. Guevara J, Lozano P, Wickizer T, Mell L, Gephart H. PMID: 11433056.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    199. Impact of the change in polio vaccination schedule on immunization coverage rates: a study in two large health maintenance organizations. Pediatrics. 2001 Apr; 107(4):671-6. Davis RL, Lieu TA, Mell LK, Capra AM, Zavitkovsky A, Quesenberry CP, Black SB, Shinefield HR, Thompson RS, Rodewald LE. PMID: 11335742.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    200. Variation in clinician recommendations for multiple injections during adoption of inactivated polio vaccine. Pediatrics. 2001 Apr; 107(4):E49. Lieu TA, Davis RL, Capra AM, Mell LK, Quesenberry CP, Martin KE, Zavitkovsky A, Black SB, Shinefield HR, Thompson RS, Rodewald LE. PMID: 11335770.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    201. Association of lower continuity of care with greater risk of emergency department use and hospitalization in children. Pediatrics. 2001 Mar; 107(3):524-9. Christakis DA, Mell L, Koepsell TD, Zimmerman FJ, Connell FA. PMID: 11230593.
      View in: PubMed   Mentions: 117     Fields:    Translation:Humans
    202. The association between greater continuity of care and timely measles-mumps-rubella vaccination. Am J Public Health. 2000 Jun; 90(6):962-5. Christakis DA, Mell L, Wright JA, Davis R, Connell FA. PMID: 10846516; PMCID: PMC1446264.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Loren's Networks
    Concepts (478)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (98)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California